AN2 Therapeutics stock price
NASDAQ:ANTX · Nasdaq · Healthcare · sector #16$3.60+1.12%Oct 21 close
Loading chart…
AN2 Therapeutics's chart data is dated 2026-10-21. There is no active technical signal. There are 3 published signal records.
AN2 Therapeutics last closed at $3.60 (+1.12%) on 2026-10-21. Listed on Nasdaq. Trailing 12 months PER is -4.4×. Its overall grade ranks 314 of 727 stocks in Healthcare.
About this company
AN2 Therapeutics last closed at $3.60 (+1.12%) on 2026-10-21. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B · 314/727
Valuation grade A
Related stocks
- AbbVieCompetitor
- Merck & CoCompetitor
- PfizerCompetitor
About AN2 Therapeutics
- What technical signals does AN2 Therapeutics (ANTX) have?
- AN2 Therapeutics current technical signals: no active technical signal.
- Is AN2 Therapeutics a cup-and-handle pattern?
- No. AN2 Therapeutics has no valid Cup signal right now.
- What published figures are available for AN2 Therapeutics?
- Market cap: $98.65M. Trailing 12 months PER: -4.4×. Latest quarter PBR: 2.12×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about AN2 Therapeutics, or open the plan table on the main site.
Ask Q about AN2 Therapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy